AbCellera Biologics (NASDAQ:ABCL) is up ~3% in Monday trading after announcing a collaboration with Biogen (NASDAQ:BIIB) to develop antibodies to treat neurological ailments. The agreement calls for ...
Source LinkAbCellera Biologics (NASDAQ:ABCL) is up ~3% in Monday trading after announcing a collaboration with Biogen (NASDAQ:BIIB) to develop antibodies to treat neurological ailments. The agreement calls for ...
Source Link
Comments